Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Minsons is a biomedical technology company based in Hangzhou, China, specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) products. The company focuses on point-of-care testing (POCT) solutions, utilizing advanced lateral flow and fluorescence immunoassay technologies to provide rapid results. Their extensive product portfolio includes diagnostic kits for infectious diseases, cardiac markers, tumor markers, and drugs of abuse. Minsons gained significant international recognition for its COVID-19 antigen and antibody rapid tests, which were distributed globally during the pandemic. The company operates a large-scale manufacturing facility and maintains a robust quality management system to serve clinical laboratories, hospitals, and over-the-counter markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Minsons.